SANA BIOTECHNOLOGY INC. - COMMON STOCK

Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute

12 May 2022 16:40:02 By Nasdaq GlobeNewswire

Sana Biotechnology Reports First Quarter 2022 Financial Results and Business Updates

10 May 2022 15:05:01 By Nasdaq GlobeNewswire

Sana Biotechnology to Present at the BofA Securities 2022 Healthcare Conference

04 May 2022 15:05:01 By Nasdaq GlobeNewswire

Sana Biotechnology to Present Data from Multiple Preclinical Studies at the American Society of Gene and Cell Therapy 25th Annual Meeting

02 May 2022 15:35:00 By Nasdaq GlobeNewswire

Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

16 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 32nd Annual Oppenheimer Healthcare Conference

09 Mar 2022 15:05:00 By Nasdaq GlobeNewswire

Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting

08 Mar 2022 15:35:00 By Nasdaq GlobeNewswire

Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct

11 Jan 2022 05:00:00 By Nasdaq GlobeNewswire

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

10 Jan 2022 15:30:00 By Nasdaq GlobeNewswire

Sana Biotechnology to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 15:05:00 By Nasdaq GlobeNewswire

Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs

12 Dec 2021 08:05:00 By Nasdaq GlobeNewswire

Sana Biotechnology Reports Third Quarter 2021 Financial Results and Business Updates

08 Nov 2021 15:05:02 By Nasdaq GlobeNewswire

Sana Biotechnology to Present Pre-Clinical Data at 2021 American Society of Hematology Annual Meeting

04 Nov 2021 08:07:03 By Nasdaq GlobeNewswire

Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs

19 Oct 2021 08:00:01 By Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

07 Sep 2021 15:05:00 By Nasdaq GlobeNewswire

Sana Biotechnology Reports Second Quarter 2021 Financial Results and Business Updates

04 Aug 2021 15:05:04 By Nasdaq GlobeNewswire

Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates

14 Jul 2021 15:10:00 By Nasdaq GlobeNewswire

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

26 Jun 2021 09:42:38 By Nasdaq GlobeNewswire

Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting

14 Jun 2021 08:15:00 By Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

02 Jun 2021 15:05:00 By Nasdaq GlobeNewswire